Tata Chemicals Past Earnings Performance
Past criteria checks 0/6
Tata Chemicals has been growing earnings at an average annual rate of 5.7%, while the Chemicals industry saw earnings growing at 14.6% annually. Revenues have been growing at an average rate of 10.9% per year.
Key information
5.7%
Earnings growth rate
5.7%
EPS growth rate
| Chemicals Industry Growth | 17.7% |
| Revenue growth rate | 10.9% |
| Return on equity | -0.8% |
| Net Margin | -2.3% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Tata Chemicals (NSE:TATACHEM) Will Be Hoping To Turn Its Returns On Capital Around
Oct 14
Is Tata Chemicals (NSE:TATACHEM) Using Too Much Debt?
Sep 18What Tata Chemicals Limited's (NSE:TATACHEM) P/S Is Not Telling You
Jul 12Increases to CEO Compensation Might Be Put On Hold For Now at Tata Chemicals Limited (NSE:TATACHEM)
Jun 20Tata Chemicals (NSE:TATACHEM) Will Pay A Smaller Dividend Than Last Year
Jun 05Tata Chemicals' (NSE:TATACHEM) Dividend Will Be Reduced To ₹15.00
May 22Some May Be Optimistic About Tata Chemicals' (NSE:TATACHEM) Earnings
May 07Should You Investigate Tata Chemicals Limited (NSE:TATACHEM) At ₹1,102?
Apr 16Improved Earnings Required Before Tata Chemicals Limited (NSE:TATACHEM) Stock's 33% Jump Looks Justified
Mar 08Tata Chemicals Limited Just Missed EPS By 31%: Here's What Analysts Think Will Happen Next
Feb 08Here's Why Tata Chemicals (NSE:TATACHEM) Can Manage Its Debt Responsibly
Jan 19Earnings Working Against Tata Chemicals Limited's (NSE:TATACHEM) Share Price
Dec 27Here's Why Tata Chemicals (NSE:TATACHEM) Can Manage Its Debt Responsibly
Sep 29Is Tata Chemicals Limited (NSE:TATACHEM) Potentially Undervalued?
Sep 08Tata Chemicals (NSE:TATACHEM) Is Increasing Its Dividend To ₹17.50
Jun 02Tata Chemicals (NSE:TATACHEM) Is Increasing Its Dividend To ₹17.50
May 19What Is Tata Chemicals Limited's (NSE:TATACHEM) Share Price Doing?
May 05At ₹955, Is Tata Chemicals Limited (NSE:TATACHEM) Worth Looking At Closely?
Jan 31Is Tata Chemicals (NSE:TATACHEM) A Risky Investment?
Dec 26Is Now The Time To Look At Buying Tata Chemicals Limited (NSE:TATACHEM)?
Sep 20We Think Tata Chemicals (NSE:TATACHEM) Can Stay On Top Of Its Debt
Aug 31Tata Chemicals' (NSE:TATACHEM) Shareholders Will Receive A Bigger Dividend Than Last Year
Jun 10Tata Chemicals (NSE:TATACHEM) Is Increasing Its Dividend To ₹12.50
May 17Tata Chemicals' (NSE:TATACHEM) Upcoming Dividend Will Be Larger Than Last Year's
May 03Tata Chemicals (NSE:TATACHEM) Has A Pretty Healthy Balance Sheet
Mar 03Is Tata Chemicals Limited (NSE:TATACHEM) Worth ₹915 Based On Its Intrinsic Value?
Feb 12Why Tata Chemicals Limited (NSE:TATACHEM) Could Be Worth Watching
Jan 26We Think Tata Chemicals (NSE:TATACHEM) Can Stay On Top Of Its Debt
Nov 23A Look At The Intrinsic Value Of Tata Chemicals Limited (NSE:TATACHEM)
Nov 04Is It Too Late To Consider Buying Tata Chemicals Limited (NSE:TATACHEM)?
Oct 18Is Tata Chemicals (NSE:TATACHEM) A Risky Investment?
Aug 03At ₹781, Is It Time To Put Tata Chemicals Limited (NSE:TATACHEM) On Your Watch List?
Jul 16Most Shareholders Will Probably Agree With Tata Chemicals Limited's (NSE:TATACHEM) CEO Compensation
Jun 25Is Tata Chemicals (NSE:TATACHEM) Using Too Much Debt?
Mar 24Tata Chemicals Limited's (NSE:TATACHEM) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Mar 08Revenue & Expenses Breakdown
Revenue & Expenses Breakdown
How Tata Chemicals makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 149,930 | -3,400 | 46,610 | 0 |
| 30 Jun 24 | 149,920 | -1,060 | 44,480 | 0 |
| 31 Mar 24 | 154,210 | 2,820 | 42,910 | 0 |
| 31 Dec 23 | 163,530 | 18,200 | 42,210 | 0 |
| 30 Sep 23 | 167,710 | 20,600 | 41,810 | 0 |
| 30 Jun 23 | 170,120 | 22,650 | 41,290 | 0 |
| 31 Mar 23 | 167,890 | 23,350 | 40,630 | 0 |
| 31 Dec 22 | 158,631 | 20,866 | 20,647 | 0 |
| 30 Sep 22 | 148,561 | 19,896 | 19,117 | 0 |
| 30 Jun 22 | 136,391 | 15,576 | 17,997 | 0 |
| 31 Mar 22 | 126,220 | 12,530 | 34,840 | 0 |
| 31 Dec 21 | 117,777 | 8,014 | 18,914 | 0 |
| 30 Sep 21 | 112,422 | 6,613 | 17,880 | 0 |
| 30 Jun 21 | 108,289 | 5,311 | 16,823 | 0 |
| 31 Mar 21 | 101,998 | 2,564 | 15,333 | 0 |
| 31 Dec 20 | 99,417 | 4,293 | 14,091 | 0 |
| 30 Sep 20 | 99,590 | 4,355 | 14,130 | 0 |
| 30 Jun 20 | 101,209 | 6,620 | 14,356 | 0 |
| 31 Mar 20 | 103,568 | 8,066 | 15,259 | 0 |
| 31 Dec 19 | 114,887 | 11,995 | 16,446 | 0 |
| 30 Sep 19 | 115,717 | 11,916 | 17,377 | 0 |
| 30 Jun 19 | 114,489 | 11,585 | 17,413 | 0 |
| 31 Mar 19 | 103,367 | 9,319 | 15,569 | 0 |
| 31 Dec 18 | 110,920 | 10,695 | 18,764 | 0 |
| 30 Sep 18 | 108,328 | 13,955 | 17,275 | 0 |
| 30 Jun 18 | 105,871 | 13,319 | 16,376 | 0 |
| 31 Mar 18 | 102,697 | 12,906 | 15,876 | 0 |
| 31 Dec 17 | 128,262 | 12,110 | 17,132 | 0 |
| 30 Sep 17 | 123,813 | 8,930 | 16,902 | 0 |
| 30 Jun 17 | 122,988 | 7,999 | 16,641 | 0 |
| 31 Mar 17 | 103,461 | 8,796 | 16,206 | 0 |
| 31 Dec 16 | 163,372 | 8,854 | 19,158 | 0 |
| 30 Sep 16 | 168,402 | 8,292 | 19,146 | 0 |
| 30 Jun 16 | 173,604 | 8,388 | 19,293 | 0 |
| 31 Mar 16 | 148,729 | 6,964 | 17,088 | 0 |
| 31 Dec 15 | 174,436 | 4,638 | 40,098 | 0 |
| 30 Sep 15 | 176,230 | 5,719 | 39,810 | 0 |
| 30 Jun 15 | 174,196 | 5,740 | 39,092 | 0 |
| 31 Mar 15 | 172,045 | 5,965 | 17,485 | 0 |
| 31 Dec 14 | 170,708 | -5,551 | 37,425 | 0 |
| 30 Sep 14 | 169,026 | -8,091 | 37,258 | 0 |
| 30 Jun 14 | 164,427 | -9,317 | 37,058 | 0 |
| 31 Mar 14 | 158,854 | -10,320 | 36,386 | 0 |
| 31 Dec 13 | 156,739 | 57 | 35,678 | 0 |
Quality Earnings: TATACHEM is currently unprofitable.
Growing Profit Margin: TATACHEM is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: TATACHEM is unprofitable, but has reduced losses over the past 5 years at a rate of 5.7% per year.
Accelerating Growth: Unable to compare TATACHEM's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: TATACHEM is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (8%).
Return on Equity
High ROE: TATACHEM has a negative Return on Equity (-0.79%), as it is currently unprofitable.